A new study published in The Journal of Clinical Endocrinology & Metabolism has found that men with type 2 diabetes and clinically low testosterone levels did not benefit from testosterone boosters, or “Low T” drugs. Testosterone boosters have more than tripled in sales over the past few years as testosterone drug manufacturers target aging men.
The study involved 88 men aged 35 to 70 and diagnosed with type 2 diabetes, as well as mild to moderate symptoms of low testosterone and erectile dysfunction. The study found that while the men’s conditions may contribute to their low testosterone, the testosterone replacement therapy was not beneficial in attempting to improve general health or sexual dysfunction.
In January, the U.S. Food and Drug Administration announced it would be launching an investigation into the health problems associated with testosterone boosters such as AndroGel and AndroDerm. Testosterone booster side effects under review include the increased risks of heart attacks and stroke.